KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Intangibles (2016 - 2025)

Resmed (RMD) has disclosed Intangibles for 12 consecutive years, with $447.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Intangibles changed N/A year-over-year to $447.1 million, compared with a TTM value of $447.1 million through Sep 2025, changed N/A, and an annual FY2025 reading of $464.9 million, down 4.33% over the prior year.
  • Intangibles was $447.1 million for Q3 2025 at Resmed, down from $464.9 million in the prior quarter.
  • Across five years, Intangibles topped out at $586.9 million in Q4 2022 and bottomed at $345.9 million in Q2 2022.
  • Average Intangibles over 5 years is $457.8 million, with a median of $456.0 million recorded in 2025.
  • The sharpest move saw Intangibles surged 59.66% in 2023, then decreased 17.07% in 2024.
  • Year by year, Intangibles stood at $372.0 million in 2021, then skyrocketed by 57.75% to $586.9 million in 2022, then decreased by 10.0% to $528.2 million in 2023, then decreased by 17.07% to $438.0 million in 2024, then rose by 2.07% to $447.1 million in 2025.
  • Business Quant data shows Intangibles for RMD at $447.1 million in Q3 2025, $464.9 million in Q2 2025, and $438.0 million in Q4 2024.